The Cambridge, MA based genomics company Helicos Biosciences has been delisted from the NASDAQ. The company received a delisting notice in April. Shortly after, Helicos cut its work force in half, laying off 40 people to focus on its diagnostics business, but in the months since it has been unable to goose its stock above the $1 mark. Article